LataMed AI Gains Insights at HLTH Europe 2026

LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company focused on telehealth infrastructure, healthcare analytics, and care coordination solutions for emerging markets, announced its attendance at HLTH Europe 2026, one of the healthcare industry's leading conferences. The event, held in June 2026, provided a platform for LataMed to engage with healthcare innovators, technology companies, providers, insurers, and digital health organizations from Europe, Latin America, and other international markets. The company highlighted that the conference reinforced the growing need for integrated digital solutions that improve patient accessibility, care coordination, and operational efficiency. Management noted increasing interest in artificial intelligence applications, telehealth infrastructure, healthcare payments, and insurance accessibility initiatives, all of which align with LataMed's strategy to develop an integrated healthcare ecosystem in Latin America.

Dr. Kevin Rodan Levy, CEO of LataMed AI, stated that HLTH Europe provided an outstanding opportunity to connect with industry professionals and observe a growing focus on integrated healthcare platforms combining accessibility, coordination, financial solutions, and technology-enabled patient engagement. He emphasized that these trends closely align with LataMed's broader healthcare ecosystem strategy and long-term vision. The company believes that engagement with global healthcare stakeholders is a critical component of its strategy as it advances its platform development. Management also observed emerging trends in AI-driven healthcare solutions and patient engagement technologies, which could support the company's ongoing efforts to build a comprehensive healthcare ecosystem encompassing telehealth, coordination tools, payment accessibility, insurance integration, pharmacy services, and AI analytics.

LataMed is currently reviewing follow-up opportunities from discussions at the conference and will provide updates on material developments. The company shared highlights on its official Instagram page and intends to continue sharing updates through its communication channels. For more information, visit https://latamed.ai or review SEC filings at www.sec.gov. The original release can be found on NEWMEDIAWIRE. LataMed AI Corp. is focused on building technology platforms to support healthcare access, patient engagement, provider coordination, emergency response, pharmacy integration, and data-driven operations in emerging markets.